Recombinant Anti-LRG1/LRG antibody [EPR12363] (ab170953)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR12363] to LRG1/LRG
- Suitable for: WB, IP
- Reacts with: Human
Related conjugates and formulations
Overview
-
Product name
Anti-LRG1/LRG antibody [EPR12363]
See all LRG1/LRG primary antibodies -
Description
Rabbit monoclonal [EPR12363] to LRG1/LRG -
Host species
Rabbit -
Tested applications
Suitable for: WB, IPmore details
Unsuitable for: ICC/IF or IHC-P -
Species reactivity
Reacts with: Human
Does not react with: Mouse, Rat -
Immunogen
Synthetic peptide within Human LRG1/LRG aa 1-100. The exact sequence is proprietary.
Database link: P02750 -
Positive control
- WB: Human plasma.
-
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant -
Concentration information loading...
-
Purity
Tissue culture supernatant -
Clonality
Monoclonal -
Clone number
EPR12363 -
Isotype
IgG -
Research areas
Associated products
-
Alternative Versions
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab170953 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
1/1000 - 1/10000. Predicted molecular weight: 38 kDa.
|
|
IP |
1/10 - 1/100.
|
Notes |
---|
WB
1/1000 - 1/10000. Predicted molecular weight: 38 kDa. |
IP
1/10 - 1/100. |
Target
-
Tissue specificity
Plasma. -
Sequence similarities
Contains 8 LRR (leucine-rich) repeats.
Contains 1 LRRCT domain. -
Cellular localization
Secreted. - Information by UniProt
-
Database links
- Entrez Gene: 116844 Human
- Omim: 611289 Human
- SwissProt: P02750 Human
- Unigene: 655559 Human
-
Alternative names
- 1300008B03Rik antibody
- 2310031E04Rik antibody
- A2GL antibody
see all
Images
-
Western blot analysis of Immunoprecipitation pellet from either 1) Human plasma lysate, or 2) 1xPBS (negative control); showing LRG1/LRG, using ab170953 at 1/10 dilution and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.
-
Anti-LRG1/LRG antibody [EPR12363] (ab170953) at 1/1000 dilution + Human plasma at 10 µg
Secondary
Goat anti-rabbit HRP at 1/2000 dilution
Developed using the ECL technique.
Predicted band size: 38 kDa
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (2)
ab170953 has been referenced in 2 publications.
- Luan L et al. Knockdown of lncRNA NEAT1 expression inhibits cell migration, invasion and EMT by regulating the miR-24-3p/LRG1 axis in retinoblastoma cells. Exp Ther Med 21:367 (2021). PubMed: 33732340
- Druhan LJ et al. Leucine Rich a-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis. PLoS One 12:e0170261 (2017). ELISA ; Human . PubMed: 28081565